Dear Women's Imaging Insider,
Here's some good news for women with dense breast tissue: Molecular breast imaging (MBI) can find three times as many cancers as conventional mammography in this population, according to researchers from the Mayo Clinic in Rochester, MN.
In an article published online this month in Radiology, lead author Deborah Rhodes, MD, and colleagues presented study results showing that adding MBI to mammography increased detection of node-negative breast cancer in dense breasts by 7.5 patients per 1,000.
But MBI uses relatively high doses of radiation, which is a cause for concern if it's to be used in a screening protocol. Find out what Rhodes and her team discovered about reducing dose with the technology, and where they see it fitting into breast cancer screening, by clicking here. As an Insider subscriber, you get access to the article before our other readers.
Once you've read our featured article, take a look at what else is going on in the Women's Imaging Digital Community:
- Get the scoop on the U.S. Food and Drug Administration's decision to ease rules on digital mammography devices.
- Find out why combining x-ray and optical tomography improves breast imaging.
- Discover what researchers have to say about radiation therapy and breast implants.
- Read whether short-interval mammography for breast cancer patients is really necessary.
As always, if you have a comment, report, or article idea to share about any aspect of women's imaging, I invite you to contact me at [email protected].
